Embecta Corp

Valuation Analysis

About the Company

Embecta Corp en bref

Embecta Corp (EMBC) is currently trading at 3,16 € with a market capitalization of 187 M €. The trailing P/E ratio stands at 1.93x, with a forward P/E of 2.09x. The 52-week range spans from 2,40 € to 13,48 €; the current price is 76.6% below the yearly high. Year-over-year revenue growth stands at -14.4%. The net profit margin stands at 10.73%.

💰 Dividende

Embecta Corp pays an annual dividend of 0,40 € per share, representing a yield of 12.64%. The payout ratio stands at 31.75%.

📊 Avis des analystes

2 analystes évaluent Embecta Corp (EMBC) au consensus : None. L'objectif de cours moyen est de 3,47 €, soit un potentiel de +9.89% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 2,60 € à 4,34 €.

Embecta Corp : la thèse d'investissement en détail

Embecta Corp (EMBC) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

With a gross margin near 61.92%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Le scénario baissier

Revenue is contracting at -14.4% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Short interest sits at 12.1% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valorisation en contexte

The EV/EBITDA multiple of 4.22x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The dividend yield near 12.64% combined with a payout ratio of 31.75% leaves room for further hikes — a track record of consecutive raises is a strong income signal.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (12.1%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Embecta Corp?

Compare top-rated brokers — low fees, trusted providers, fully regulated.